Dr. Andre Posner Featured in In-Depth Online Interview Highlighting His Legacy in Medicine and Medical Education
The feature explores topics ranging from his upbringing in a multigenerational home in Merion Station, Pennsylvania, to the profound influence of his father's work eradicating smallpox in Africa during his early years in Dakar, Senegal. It also delves into his teaching style, the evolving landscape of healthcare, and the importance of mindfulness, strategic thinking, and empathy in both medicine and life.
In the interview, Dr. Posner shares deeply personal reflections and hard-earned wisdom gained from decades of clinical practice at institutions including Frankford Hospital, Main Line Health, and Penn Medicine. Readers will gain insight into the values that guide his work: trust, clarity, adaptability, and presence.
'This was an opportunity to speak not just as a doctor, but as a human being shaped by patients, mentors, and life itself,' said Dr. Posner. 'I'm grateful to share my story and, hopefully, inspire others in the field to lead with empathy and intention.'
Dr. Posner's feature is part of a broader effort to spotlight voices in medicine who are making a difference not only through clinical excellence but also through education, mentorship, and compassion.
To read the full article, visit the website here.
About Dr. Andre Posner:
Dr. Andre Posner is an award-winning physician and educator known for his commitment to patient care and medical mentorship. With over two decades of hospitalist experience and numerous teaching honors—including the D. Stratton Woodruff Award and Faculty Award for Resident Teaching—Dr. Posner continues to be a guiding force in medicine. He is currently affiliated with Penn Medicine and remains active in both clinical practice and medical education.
Media Contact
Contact Person: Andre Posner
Email: Send Email
City: Philadelphia
State: Pennsylvania
Country: United States
Website: https://www.drandreposner.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 days ago
- Globe and Mail
Dr. Sagy Grinberg Launches Nationwide Healing Hands Scholarship to Support Future Leaders in Healthcare
Dr. Sagy Grinberg Launches Nationwide Healing Hands Scholarship to Support Future Leaders in Healthcare New York City, NY - In a significant initiative aimed at fostering the growth of future healthcare leaders, board-certified physician Dr. Sagy Grinberg officially announces the Dr. Sagy Grinberg Healing Hands Scholarship for Healthcare. This nationwide scholarship is now open to undergraduate students across the United States who are pursuing careers in healthcare-related fields, including but not limited to medicine, nursing, public health, and biomedical sciences. With a well-established career in internal medicine and infectious diseases, Dr. Sagy Grinberg brings years of clinical experience and academic dedication to this philanthropic effort. As the lead physician of his own private practice, Dr. Sagy Grinberg has long understood the value of supporting emerging professionals who demonstrate both compassion and a commitment to evidence-based care. This scholarship marks a new chapter in his mission to help build a stronger, more innovative healthcare workforce. The Dr. Sagy Grinberg Healing Hands Scholarship for Healthcare invites undergraduate students currently enrolled at accredited U.S. institutions to submit an original essay addressing the following prompt: 'What inspires you to pursue a career in healthcare, and how do you plan to make a meaningful impact in the lives of others through your future work?' The essay should be between 750 and 1,000 words and reflect the applicant's personal motivation, vision, and potential contributions to the healthcare field. Applications must be submitted by January 15, 2026, and the selected recipient will be announced on February 15, 2026. Dr. Sagy Grinberg created this scholarship not only to reward academic ambition but also to recognize individuals who seek to bring about tangible, positive change in their communities through healthcare. 'The future of medicine relies on dedicated individuals with the heart and resilience to improve lives,' says Dr. Sagy Grinberg. 'This scholarship is designed to uplift those students and help them stay focused on their journey.' The scholarship is open to students nationwide without restriction to geographic location, offering a unique opportunity to applicants regardless of where they study in the United States. In addition to his practice in New York City, Dr. Sagy Grinberg has made considerable contributions to the fields of infection control, hospital and outpatient medicine, and medical research. He remains actively engaged in clinical advancement and continues to mentor rising medical professionals. Through this scholarship, he aims to provide financial assistance while also inspiring students to uphold high standards of patient care and clinical integrity. Interested applicants can learn more and apply via the official scholarship website: Media Contact Company Name: Dr. Sagy Grinberg Scholarship Contact Person: Dr. Sagy Grinberg Email: Send Email City: New York City State: New York Country: United States Website:
CBC
6 days ago
- CBC
Dr. Peter Lin makes the case for avoiding infections
New medical research indicates common respiratory illnesses, like COVID-19 or the flu can potentially trigger dormant tumour cells for some breast cancer patients. The findings, published recently in The Journal of Nature, was based on mouse studies as well as meta-analysis of human patients. Dr. Lin explains the new research.
Globe and Mail
08-08-2025
- Globe and Mail
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
NEWTOWN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) ('Traws Pharma', 'Traws' or 'the Company'), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced plans to host a conference call and webcast on Thursday, August 14, 2025 at 8:30 AM ET to discuss financial results for the second quarter ended June 30, 2025 and recent business progress. Conference Call and Webcast Information Date: Thursday, August 14, 2025, at 8:30 AM ET Participant Dial-in (U.S.): 1-877-407-0789 Participant Dial-in (International): 1-201-689-8562 Conference ID: 13754425 Webcast Access: Click Here A replay of the webcast will be available on the Investors section of the Traws website at About Traws Pharma, Inc. Traws Pharma is a clinical stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. Traws integrates antiviral drug development, medical intelligence and regulatory strategy to meet real world challenges in the treatment of viral diseases. We are advancing novel investigational oral small molecule antiviral agents that have potent activity against difficult to treat or resistant virus strains that threaten human health: bird flu and seasonal influenza, and COVID-19/Long COVID. Tivoxavir marboxil is in development as a single dose treatment for bird flu and seasonal influenza, targeting the influenza cap-dependent endonuclease (CEN). Ratutrelvir is in development as a ritonavir-independent COVID treatment, targeting the Main protease (Mpro or 3CL protease). Traws is actively seeking development and commercialization partners for its legacy clinical oncology programs, rigosertib and narazaciclib. More details can be found on Traws' website at For more information, please visit and follow us on LinkedIn. Traws Pharma Contact: Charles Parker Traws Pharma, Inc. cparker@ Investor Contact: John Fraunces LifeSci Advisors, LLC 917-355-2395 jfraunces@
